CVR 26819601Private limited company (ApS)Engroshandel med læge- og hospitalsartikler (464620)Arne Jacobsens Allé 17, 2300 København SFounded 30 Sep 2002
COVIDIEN DANMARK ApS
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about COVIDIEN DANMARK ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
0
CVR, 2016
Revenue
214M
DKK, annual report 2015
+1.4% on 2014
Result
+4.8M
DKK, annual report 2015
Equity
49.1M
DKK, annual report 2015
Medtronic Norge AS100% of capital and votes, until 27 May 2016
Mohammad Khairi Nizam Bin Amzahuntil 27 May 2016
No current owner is registered.
100% of capital and votes30 Sep 2002 to 10 Dec 2015
100% of capital and votes11 Dec 2015 to 27 May 2016
Showing 25 of 30. The list below has every one.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
May 2016, monthly: 23 employees, 22 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Q4 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | No count | 19 | 23 | 23 | 25 | 30 | 29 | 27 | No count | No count | No count | No count | 32 | 30 | 26 | 26 | 26 | 27 | 26 | 26 | 27 | 26 | 25 | 23 | 26 | 24 | 24 | 24 | 22 | 22 | 22 | 22 | 23 |
| FTE | 0 | 16 | 20 | 21 | 23 | 22 | 25 | 29 | 30 | 27 | 26 | 29 | 30 | 30 | 27 | 24 | 25 | 26 | 24 | 25 | 26 | 25 | 24 | 22 | 24 | 23 | 23 | 22 | 21 | 21 | 21 | 21 | 22 |
| Series | Quarterly | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest May 2016, published 29 Jul 2016.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2015, DKK: Revenue 214M, Operating profit 6.9M, Result for the year 4.8M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2015, DKK: Total assets 90.9M, Equity 49.1M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2011 | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|---|
| Revenue | Not reported | Not reported | 204,437 | 211,054 | 213,985 |
| Operating profit | Not reported | Not reported | +15,767 | +3,967 | +6,863 |
| Result for the year | Not reported | Not reported | +10,222 | +3,934 | +4,798 |
| Equity | Not reported | Not reported | 40,334 | 44,268 | 49,066 |
| Total assets | Not reported | Not reported | 89,763 | 90,238 | 90,916 |
| Employees (average) | Not reported | Not reported | 30 | 24 | Not reported |
2015: The 2015 report shows 2014 in amounts a thousand times smaller than the 2014 report does, and this filing states its share capital a thousand times smaller than CVR registers it, so it tagged its amounts in the wrong unit. Dandex multiplied them by a thousand.
Annual report 2015
1 Oct 2014 to 30 Sep 2015, published 3 Mar 2016
Annual report 2014
1 Oct 2013 to 30 Sep 2014, published 20 Mar 2015
Annual report 2013
1 Oct 2012 to 30 Sep 2013, published 1 Apr 2014
Annual report 2012
1 Oct 2011 to 30 Sep 2012, published 7 Mar 2013
Annual report 2011
1 Oct 2010 to 30 Sep 2011, published 1 Mar 2012
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingNot read from the announcement | None | None | None | 500,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2011 | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|---|
| Revenue growth (omsætningsvækst) | Not reported | Not reported | -5.8% | 3.2% | 1.4% |
| EBIT margin (overskudsgrad) | Not reported | Not reported | 7.7% | 1.9% | 3.2% |
| EBITDA | Not reported | Not reported | 16,636note 1 | 4,767note 1 | Not reportednote 2 |
| EBITDA margin (EBITDA-margin) | Not reported | Not reported | 8.1%note 1 | 2.3%note 1 | Not reportednote 2 |
| Employee growth (vækst i antal ansatte) | Not reported | Not reported | -6.3% | -20% | Not reportednote 3 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | Not reported | Not reported | 813note 4 | 1,326note 4 | Not reportednote 5 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Merger (fusion), as the ceasing company (ophørende selskab)
Source: CVR, read 20 Nov 2026.
33 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er d. 27.05.2016 opløst ved fusion med CVR-nummer: 18491370 MEDTRONIC DANMARK A/S.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er d. 27.05.2016 opløst ved fusion med CVR-nummer: 18491370 MEDTRONIC DANMARK A/S.
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 18491370 MEDTRONIC DANMARK A/S (fortsættende) og CVR-nummer: 26819601 COVIDIEN DANMARK ApS (ophørende), der tillige driver virksomhed under navnene TYCHO HEALTHCARE DENMARK ApS.
Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i CVR-nummer: 18491370 MEDTRONIC DANMARK A/S og CVR-nummer: 26819601 COVIDIEN DANMARK ApS må antages at være tilstrækkeligt sikrede efter fusionen.
Revision:
Fratrådte:
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 30.10.2015.
Tiltrådte:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 30.10.2015.
Virksomheden er omdannet til et anpartsselskab med CVR-nummer: 26819601 Vedtægter ændret: 16.09.2015
Nyt navn: COVIDIEN DANMARK ApS
Nyt binavn: TYCHO HEALTHCARE DENMARK ApS
Slettet binavn: TYCO HEALTHCARE DENMARK A/S
CVR-nummer:
26819601.
NAVN:
COVIDIEN DANMARK A/S.
Adresse: c/o Medtronic Danmark A/S, Arne Jacobsens Allé 17, 7., 2300 København S.
Kommune: København.
Ny adresse: c/o Medtronic Danmark A/S, Arne Jacobsens Allé 17, 7., 2300 København S
Ny kommune: København
CVR-nummer
26819601.
NAVN:
COVIDIEN DANMARK A/S.
Adresse: c/o Medtronic Danmark A/S, Arne Jacobsens Allé 7, 7., 2300 København S.
Kommune: København.
Ny adresse: c/o Medtronic Danmark A/S, Arne Jacobsens Allé 17, 7., 2300 København S
Ny kommune: København
CVR-nummer
26819601.
NAVN:
COVIDIEN DANMARK A/S.
Adresse: Arne Jacobsens Allé 7, 5., 2300 København S.
Kommune: København.
Ny adresse: c/o Medtronic Danmark A/S, Arne Jacobsens Allé 7, 7., 2300 København S
Ny kommune: København
Bestyrelse:
Tiltrådt som formand:
Mikael Raunkjær, den 13.12.2013.
Udtrådt af bestyrelsen:
Marja Riitta Sinikka Dahlman, den 13.12.2013, Geir Hugo Ødegård-Hansen, den 01.10.2013, Panu Samuel Lauha, den 13.12.2013, Sari-Sisko Katariina Ylinampa, den 20.11.2013.
Indtrådt i bestyrelsen:
Arnolda Gabriëlla Johanna Mari a van Berne, 6582 AA Heumen, Holland, den 13.12.2013.
Bestyrelse:
Udtrådt af bestyrelsen:
Göran Tomas Reine Alm, den 17.04.2013.
Indtrådt i bestyrelsen:
Jan Christer Eriksson, den 17.04.2013.
Ny adresse:
Arne Jacobsens Allé 7, 5., 2300 København S.
Bestyrelse:
Udtrådt af bestyrelsen:
Kenni Dieckmann Christoffersen, den 29.02.2012.
Indtrådt i bestyrelsen:
Geir Hugo Ødegård-Hansen, den 29.02.2012, Mohammad Khairi Nizam Bin Amzah, den 29.02.2012, Mikael Raunkjær, den 29.02.2012.
Direktion:
Udtrådt af direktionen:
Kenni Dieckmann Christoffersen, den 29.02.2012.
Indtrådt i direktionen:
Mohammad Khairi Nizam Bin Amzah, den 29.02.2012.
Bestyrelse:
Udtrådt af bestyrelsen:
Carl Lennart Ekroth, den 16.09.2010, Karin Birgitta Ericsson, den 16.09.2010.
Indtrådt i bestyrelsen:
Wilhelmus Johannes Maria van Zuilen, den 16.09.2010, Kenni Dieckmann Christoffersen, den 16.09.2010, Panu Samuel Lauha, den 16.09.2010, Sari-Sisko Katariina Ylinampa, den 16.09.2010.
Direktion:
Udtrådt af direktionen:
Carl Lennart Ekroth, den 16.09.2010.
Indtrådt i direktionen:
Kenni Dieckmann Christoffersen (adm. dir), den 16.09.2010.
Vedtægter ændret:
21.06.2010.
Bestyrelse:
Udtrådt af bestyrelsen:
Folke Magnus Halvor Back, den 22.02.2010, Morten Gunvad, den 22.02.2010.
Bestyrelse:
Udtrådt af bestyrelsen:
Jon Terje Heimdal, den 30.11.2009, Helena Paula Neto Contreiras de Almeida, den 30.11.2009.
Indtrådt i bestyrelsen:
Carl Lennart Ekroth, den 30.11.2009.
Direktion:
Udtrådt af direktionen:
Helena Paula Neto Contreiras de Almeida, den 30.11.2009.
Indtrådt i direktionen:
Carl Lennart Ekroth (adm. dir), den 30.11.2009.
Ny adresse:
Langebrogade 6E, 3. tv., 1411 København K.
Bestyrelse:
Udtrådt af bestyrelsen:
Ulrika Frisk, den 30.04.2008.
Indtrådt i bestyrelsen:
Said Richard Karroum, den 30.04.2008.
Bestyrelse:
Udtrådt af bestyrelsen:
Joakim Sten Fondelius, den 28.03.2008.
Indtrådt i bestyrelsen:
Helena Paula Neto Contreiras de Almeida, den 28.03.2008.
Direktion:
Udtrådt af direktionen:
Joakim Sten Fondelius, den 28.03.2008.
Indtrådt i direktionen:
Helena Paula Neto Contreiras de Almeida (adm. dir), den 28.03.2008.
Vedtægter ændret:
26.10.2007.
Nyt navn:
COVIDIEN DANMARK A/S.
Nyt binavn: TYCO HEALTHCARE DENMARK A/S (COVIDIEN DANMARK A/S).
Vedtægter ændret:
20.08.2007.
Bestyrelse:
Udtrådt af bestyrelsen:
Michelangelo Stefani, den 20.08.2007, Jose Eduardo Almeida, den 20.08.2007, David Roy West, den 20.08.2007.
Indtrådt i bestyrelsen:
Marja Riitta Sinikka Dahlman (formand), den 20.08.2007, Göran Tomas Reine Alm, den 20.08.2007, Folke Magnus Halvor Back, den 20.08.2007, Joakim Sten Fondelius, den 20.08.2007, Ulrika Frisk, den 20.08.2007, Morten Gunvad, den 20.08.2007, Jon Terje Heimdal, den 20.08.2007.
Direktion:
Udtrådt af direktionen:
Said Richard Karroum, den 20.08.2007.
Indtrådt i direktionen:
Joakim Sten Fondelius (adm. dir), den 20.08.2007.
Selskabet tegnes af den samlede bestyrelse eller af to bestyrelsesmedlemmer i forening.
Bestyrelse:
Udtrådt af bestyrelsen:
Giorgio Domenico Ninzoli, den 03.07.2006.
Indtrådt i bestyrelsen:
Jose Eduardo Almeida, den 03.07.2006.
Bestyrelse:
Udtrådt af bestyrelsen:
Detlev Roger Dullien, den 30.09.2004.
Indtrådt i bestyrelsen:
Giorgio Domenico Ninzoli, den 30.09.2004.
Revision:
Indtrådt i revisionen:
CVR-NR. 24213714 DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB, H.C. Andersens Boulevard 2, 1780 København V, den 21.09.2004.
Revision:
Udtrådt af revisionen:
Statsaut. revisor Svend Aage Nielsen, den 09.09.2004.
Stiftelsesdato:
30.09.2002.
Seneste vedtægtsdato:
30.09.2002.
Kapital:
kr. 500.000,00.
Indbetalingsmåde:
kontant kr. 500.000,00 til kurs 100,00.
Stifter:
TYCO GROUP S.AR.L, den 30.09.2002.
Bestyrelse:
Michelangelo Stefani (formand), den 30.09.2002, Detlev Roger Dullien, den 30.09.2002, David Roy West, den 30.09.2002.
Direktion:
Said Richard Karroum (adm. dir), den 30.09.2002.
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af en direktør.
Revision:
Statsaut. revisor Svend Aage Nielsen, 4200 Slagelse, den 30.09.2002.
Første regnskabsår:
30.09.2002 - 30.09.2003.
Regnskabsår:
01.10 - 30.09.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 20 Nov 2026.
What Pro holds for COVIDIEN DANMARK ApS:
Have Pro? Sign in.
P-number 1009375410Arne Jacobsens Allé 17, 2300 København S